Autor: "Elizabeth E Brown" - OpacWWW

Tytuł:: A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN-035.
Autorzy:: Bauermeister J; University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lin W; University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Tingler R; University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Liu A; Bridge HIV at the San Francisco Department of Public Health, San Francisco, California, USA.
Chariyalertsak S; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Hoesley C; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Gonzales P; IMPACTA, Asociación Civil Impacta Salud y Educación, San Miguel CRS, Lima, Perú.
Ho K; University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kayange N; Blantyre CRS, Johns Hopkins University Research Project, Blantyre, Malawi.
Phillips TP; Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
Johnson S; FHI 360, Durham, North Carolina, USA.
Brown E; Statistical Center for HIV/AIDS Research & Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Zemanek J; Statistical Center for HIV/AIDS Research & Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Jacobson CE; FHI 360, Durham, North Carolina, USA.
Doncel GF; CONRAD, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Piper J; Division of AIDS, United States National Institute of Health, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.; Pokaż więcej
Corporate Authors:: MTN-035 Protocol Team for the Microbicide Trials Network
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26219.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Anti-Infective Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Sexual and Gender Minorities*
Humans ; Male ; Homosexuality, Male ; Sexual Behavior ; United States ; Female ; Adolescent ; Young Adult ; Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: To degas or not to degas? The effectiveness of pharmaceuticals in reducing the impact of bowel volume variations during liver SBRT treatment.
Autorzy:: Haslam P; Queensland University of Technology, Faculty of Health, School of Clinical Sciences, Brisbane, Queensland, Australia.; Radiation Oncology Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Brown E; Queensland University of Technology, Faculty of Health, School of Clinical Sciences, Brisbane, Queensland, Australia.; Radiation Oncology Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Burbery J; Queensland University of Technology, Faculty of Health, School of Clinical Sciences, Brisbane, Queensland, Australia.
Hargrave C; Queensland University of Technology, Faculty of Health, School of Clinical Sciences, Brisbane, Queensland, Australia.; Radiation Oncology Princess Alexandra Hospital, Raymond Terrace, Brisbane, Queensland, Australia.
Lee YY; Radiation Oncology Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Pokaż więcej
Źródło:: Journal of medical radiation sciences [J Med Radiat Sci] 2024 Mar; Vol. 71 (1), pp. 156-162. Date of Electronic Publication: 2023 Aug 16.
Typ publikacji:: Case Reports
MeSH Terms:: Radiosurgery*/adverse effects
Liver Neoplasms*/radiotherapy
Liver Neoplasms*/etiology
Liver Neoplasms*/surgery
Humans ; Pharmaceutical Preparations ; Simethicone

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021.
Autorzy:: Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Marcelin JR; Division of Infectious Diseases, Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Pettifor AE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Janes H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Brown E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Neradilek M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Yen C; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Andriesen J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Espy N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Trahey M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Fischer RSB; Department of Epidemiology and Biostatistics, School of Public Health, Texas A&M University, College Station, Texas, USA.
DeSouza CA; Department of Integrative Physiology, University of Colorado, Boulder, Colorado, USA.
Shisler JL; Department of Microbiology, University of Illinois, Urbana, Illinois, USA.
Connick E; Department of Medicine, University of Arizona, Tucson, Arizona, USA.
Houpt ER; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Chu HY; Department of Medicine, University of Washington, Seattle, Washington, USA.
McCulloh RJ; Children's Hospital and Medical Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Becker-Dreps S; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Vielot NA; Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Kalbaugh CA; Department of Public Health Sciences, Clemson University, Clemson, South Carolina, USA.
Cherabuddi K; Department of Medicine, University of Florida, Gainesville, Florida, USA.
Krueger KM; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Rosenberg M; Center for Sexual Health Promotion, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, USA.
Greenberg RN; Department of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Joaquin A; Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, California, USA.
Immergluck LC; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, Georgia, USA.
Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Laboratory Medicine, University of Washington,Seattle, Washington, USA.
Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Pokaż więcej
Źródło:: Open forum infectious diseases [Open Forum Infect Dis] 2023 Nov 02; Vol. 10 (11), pp. ofad511. Date of Electronic Publication: 2023 Nov 02 (Print Publication: 2023).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington.
Autorzy:: Ramchandani MS; Department of Medicine, University of Washington, Seattle, Washington, USA.; HIV/STI/HCV Program, Public Health-Seattle & King County, Seattle, Washington, USA.
Berzkalns A; HIV/STI/HCV Program, Public Health-Seattle & King County, Seattle, Washington, USA.
Cannon CA; Department of Medicine, University of Washington, Seattle, Washington, USA.; HIV/STI/HCV Program, Public Health-Seattle & King County, Seattle, Washington, USA.
Dombrowski JC; Department of Medicine, University of Washington, Seattle, Washington, USA.; HIV/STI/HCV Program, Public Health-Seattle & King County, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Brown E; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Chow EJ; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Communicable Disease Epidemiology and Immunizations, Public Health-Seattle & King County, Seattle, Washington, USA.
Barash E; HIV/STI/HCV Program, Public Health-Seattle & King County, Seattle, Washington, USA.
Pogosjans S; Communicable Disease Epidemiology and Immunizations, Public Health-Seattle & King County, Seattle, Washington, USA.
Smith D; Communicable Disease Epidemiology and Immunizations, Public Health-Seattle & King County, Seattle, Washington, USA.
Golden MR; Department of Medicine, University of Washington, Seattle, Washington, USA.; HIV/STI/HCV Program, Public Health-Seattle & King County, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Pokaż więcej
Źródło:: Open forum infectious diseases [Open Forum Infect Dis] 2023 Oct 24; Vol. 10 (11), pp. ofad528. Date of Electronic Publication: 2023 Oct 24 (Print Publication: 2023).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: SARS-CoV-2 vaccination and infection in ozanimod-treated participants with relapsing multiple sclerosis.
Autorzy:: Cree BAC; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
Maddux R; Bristol Myers Squibb, Princeton, New Jersey, USA.
Bar-Or A; Department of Neurology, Center for Neuroinflammation, and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hartung HP; Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Palacký University Olomouc, Olomouc, Czech Republic.
Kaur A; Bristol Myers Squibb, Princeton, New Jersey, USA.
Brown E; Bristol Myers Squibb, Princeton, New Jersey, USA.
Li Y; Bristol Myers Squibb, Princeton, New Jersey, USA.
Hu Y; Bristol Myers Squibb, Princeton, New Jersey, USA.
Sheffield JK; Bristol Myers Squibb, Princeton, New Jersey, USA.
Silva D; Bristol Myers Squibb, Princeton, New Jersey, USA.
Harris S; Bristol Myers Squibb, Princeton, New Jersey, USA.; Pokaż więcej
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Oct; Vol. 10 (10), pp. 1725-1737. Date of Electronic Publication: 2023 Aug 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: COVID-19*
Multiple Sclerosis*
Humans ; COVID-19 Vaccines/adverse effects ; SARS-CoV-2 ; RNA, Messenger ; Vaccination/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Flexor tenotomies for the treatment of bilateral wrist contracture after traumatic brain injury: A case report.
Autorzy:: Brown E; Texas Tech University Health Sciences Center Lubbock Texas USA.
Kastner T; Texas Tech University Health Sciences Center Lubbock Texas USA.
Harder J; Department of Orthopaedic Hand Surgery Texas Tech University Health Sciences Center Lubbock Texas USA.
Cox C; Department of Orthopaedic Hand Surgery Texas Tech University Health Sciences Center Lubbock Texas USA.
MacKay B; Department of Orthopaedic Hand Surgery Texas Tech University Health Sciences Center Lubbock Texas USA.; Pokaż więcej
Źródło:: Clinical case reports [Clin Case Rep] 2023 Sep 22; Vol. 11 (9), pp. e7869. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).
Typ publikacji:: Case Reports

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Elizabeth E Brown"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język